1/29
Looks like no tags are added yet.
Sjogren's Syndrome
A chronic autoimmune dysfunction of the lacrimal and salivary glands characterized by lymphocytic infiltration of exocrine glands, leading to dry mouth (xerostomia) and dry eyes (keratoconjunctivitis sicca).
Keratoconjunctivitis Sicca
Drying of the cornea and conjunctiva caused by decreased tear production and lymphocytic and plasma cell infiltration of the lacrimal glands.
Xerostomia
Severe dryness of the mouth resulting from salivary gland hypofunction, causing difficulty swallowing dry foods, increased thirst, and elevated risk of dental caries.
Schirmer's Test
A diagnostic office test using filter paper placed inside the lower eyelid to quantify tear production over time when evaluating dry eye symptoms.
Scleroderma (Systemic Sclerosis/SSc)
A rare chronic autoimmune disease characterized by diffuse tissue fibrosis of the skin and internal organs, endothelial cell injury, and overproduction of extracellular matrix.
Limited Systemic Sclerosis
A scleroderma subtype (~65% of cases) affecting the face and extremities distal to the knees/elbows, marked by a better overall prognosis but higher rates of digital ischemia and pulmonary hypertension.
Diffuse Systemic Sclerosis
A severe scleroderma subtype (~30% of cases) marked by rapid skin thickening involving the trunk and proximal extremities, with higher risks of pulmonary interstitial fibrosis, renal crisis, and cardiac complications.
CREST Syndrome
A clinical acronym describing limited scleroderma, consisting of Calcinosis cutis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasias.
Raynaud's Phenomenon
Cold- or stress-induced vasospasm of digital arteries causing episodic cyanosis, pallor, and rubor of the fingers, frequently serving as the initial presenting sign of scleroderma.
Anti-SCL-70 (Anti-DNA Topoisomerase I)
An autoantibody marker tested on scleroderma panels that correlates with diffuse cutaneous involvement and pulmonary fibrosis.
Anti-Centromere Antibodies (ACA)
An autoantibody marker evaluated during laboratory workup that is highly specific for limited scleroderma (CREST syndrome).
Polymyositis
A systemic autoimmune disorder marked by activated immune cell invasion of healthy muscle fibers, causing capillary injury, muscle cell necrosis, and progressive, symmetric proximal muscle weakness.
Dermatomyositis
A systemic inflammatory myopathy presenting with the proximal muscle weakness of polymyositis accompanied by pathognomonic skin rashes and a significantly increased risk of underlying malignancy (up to 25%).
Gottron Papules
Scaly, erythematous papules or patches over the dorsum of the MCP, PIP, and DIP joints, serving as a classic physical marker for dermatomyositis.
Heliotrope Rash
A dusky violaceous erythema with periorbital edema surrounding the eyelids, characteristic of dermatomyositis.
Shawl Sign
A characteristic confluent erythematous rash across the posterior neck, shoulders, and upper chest/back seen in dermatomyositis.
Mechanic's Hands
Hyperkeratotic, scaling, and fissured skin changes along the palmar and lateral aspects of the fingers associated with inflammatory myopathies.
Holster Sign
A characteristic cutaneous erythematous eruption appearing over the lateral aspect of the hips and thighs in dermatomyositis.
Serum Creatine Kinase (CK)
An enzyme found predominantly in skeletal muscle, cardiac tissue, and brain that elevates markedly during acute muscle necrosis in polymyositis and dermatomyositis.
Anti-Jo-1
A myositis-specific autoantibody (MSA) evaluated on laboratory panels when investigating inflammatory muscle diseases.
Polymyalgia Rheumatica (PMR)
A chronic inflammatory disease occurring in patients >50 years old characterized by severe morning stiffness (>45 minutes) and pain in the shoulder and pelvic girdles without intrinsic muscle weakness.
Giant Cell Arteritis (GCA / Temporal Arteritis)
A large-vessel vasculitis affecting the aorta and extracranial tributaries of the carotid artery (temporal artery) that presents with temporal headaches, scalp tenderness, jaw claudication, and a high risk of ischemic blindness.
Temporal Artery Biopsy
The definitive gold-standard diagnostic procedure performed to confirm Giant Cell Arteritis prior to or shortly after starting high-dose systemic steroids.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
A complex multisystem disorder defined by a clinical triad of profound fatigue impairing function, post-exertional malaise, and unrefreshing sleep lasting over 6 months.
Post-Exertional Malaise (PEM)
A cardinal diagnostic feature of ME/CFS involving a disproportionate worsening of physical and cognitive symptoms following minor stressors.
Complex Regional Pain Syndrome (CRPS)
A painful extremity condition featuring autonomic and vasomotor instability, hyperalgesia, allodynia, and trophic changes, divided into Type I (no nerve lesion) and Type II (documented nerve injury).
Budapest Criteria
The formal diagnostic framework for CRPS requiring continuing pain disproportionate to an inciting event alongside documented signs and symptoms across sensory, vasomotor, sudomotor/edema, and motor/trophic categories.
Adult-Onset Still's Disease (AOSD)
A systemic autoinflammatory disorder defined by daily high-spiking fevers (>39°C), an evanescent salmon-colored maculopapular rash during fever spikes, pharyngitis, arthritis, extreme leukocytosis, and markedly elevated serum ferritin.
Yamaguchi Criteria
The validated diagnostic criteria set for Adult-Onset Still's Disease requiring ≥5 features (with at least 2 major criteria such as high fever, arthralgias, characteristic rash, or marked neutrophilic leukocytosis).
Mixed Connective Tissue Disease (MCTD)
An overlap autoimmune disorder combining clinical features of SLE, scleroderma, polymyositis, and RA in the mandatory presence of high-titer Anti-U1 RNP autoantibodies